Answers are grounded in this paper and cite their sources.
The chromosome 3p21 locus harbors 3 frequently mutated ccRCC tumor suppressor genes. BAP1 and SETD2 mutations (6%-12%) are associated with worse CSS, suggesting their roles in disease progression. PBRM1 mutations (30%-34%) do not impact CSS, implicating its principal role in the tumor initiation. Future efforts should focus on therapeutic interventions and further clinical, pathologic, and molecular interrogation of this novel class of tumor suppressors.
No takes yet. Share an insight, caveat, or question.
Hakimi et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: